The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Fresenius Kabi will be fully responsible for the marketing of Vifor’s intravenous iron portfolio in China.

On the heels of a late-stage clinical trial failure, Vifor Pharma has moved to bolster its pipeline by acquiring Spain's Sanifit and fellow Swiss biotech Inositec for a combined value of €225 ...

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

Sanofi S.A. Part Cert 0.06% €8.19M ...

Walmart is refreshing its logo for the first time in nearly two decades, highlighting its evolution while also serving as a nod to its past, the big-box retailer announced Monday. The word mark on ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,07,283.90 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

After hours: January 17 at 6:42:43 PM EST Loading Chart for RPRX ...

Companies that have grown profits and net profit margins over the past 12 months ...

Truist Financial analyst Joon Lee maintained a Buy rating on Catalyst Pharma (CPRX – Research Report) today. The company’s shares closed yesterday at $22.21. Discover outperforming stocks and ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

IPC Indice de Precios Y Cotizaciones 49,940.89-7.26-0.01% ...

06:35 EST Traws Pharma (TRAW) files to sell 7.23M shares of common stock for holders Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline ...